Baxter Healthcare

Activities: Manufacturing

Trending Articles

  1. Touchlight becomes the first synthetic DNA API manufacturer to receive GMP certification The CDMO's Hampton, UK facility has received GMP certification to produce investigational APIs and critical starting materials for DNA vaccines and non-viral gene therapies
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Managing airflow, contamination risks and technician well-being with biological safety cabinets Microbiology labs and other facilities researching biohazardous materials and pathogens such as bacteria, viruses and fungi must avoid contamination. It is critical to ensure...
  3. Daiichi Sankyo and BioMed X Institute join forces to develop multi-specific biologics for cancer therapy Through this collaboration, they aim to discover and develop novel target combinations for bi- and multi-specific biologics for the treatment of solid tumours
  4. Teva Pharmaceuticals, Klinge Pharma and Formycon join forces to commercialise Eylea biosimilar FYB203, which will be marketed under the name AHZANTIVE®3 if approved by the EMA, will be commercialised by Teva Pharmaceuticals in the majority of Europe and Israel
  5. Vetter launches new iteration of the V-OVS syringe closure system The new version is optimised to protect the integrity of the injectable product with easier handling characteristics and an intuitive opening mechanism

Upcoming event

Pharmapack

22 – 23 January 2025 | Exhibition | Paris, France See all

Related Content

Drug Delivery

US FDA approves cardiovascular medicine from Baxter

The premixed format of eptifibatide to treat acute coronary syndrome is the first of its kind available in a flexible container
You need to be a subscriber to read this article.
Click here to find out more.
Training & Education

Updating the Book

Modern methods for modern times
Regulatory

Indian pricing authority to address overcharging by pharma companies

NPPA has decided to chase drug majors for defaulting on penalties that have been imposed for overcharging consumers for medicines
Regulatory

Baxter recalls multivitamin powder after glass particles are found

Preliminary investigations point to an isolated event, says MHRA
Containment

Extract delivers 'remarkable service' to an international healthcare company

When any request is received, the After Market department makes every effort to resolve site issues within the shortest possible time frame
Manufacturing

Update on SafeBridge potent compound safety certification programme

The programme provides drug innovators with an independent assessment of a manufacturing company’s ability to safely produce potent APIs and drug products
Regulatory

Myelofibrosis – pacritinib

Myelofibrosis is a chronic, serious and life-threatening disorder of the bone marrow with a median survival of six years - and much less for very high risk patients
Subscribe now